David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about “the top 10 heart health developments in 2021.”
David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about “the top 10 heart health developments in 2021.”
The analysis looked at sotatercept use in patients with pulmonary arterial hypertension and the safety and utilization across phenotype groups.
View DetailsThe mMRC and CAT are recommended for use to inform initial and long-term therapy, but both were developed and validated outside the United States with somewhat homogeneous populations.
View Details